T. Mino et al. / Tetrahedron Letters 42 (2001) 4837–4839
4839
In conclusion, we have prepared novel chiral phos-
NMR (300 MHz, CDCl3) l 0.68 (t, 6.9 Hz, 3H), 0.83–
0.87 (m, 1H), 0.90 (s, 3H), 0.94–0.98 (m, 1H), 1.21–1.34
(m, 3H), 1.36–1.42 (m, 1H), 1.41 (s, 3H), 1.50 (dd, 7.9
and 13.3 Hz, 1H), 1.60–1.72 (m, 2H), 1.77–1.84 (m, 1H),
1.98–2.03 (m, 1H), 2.05 (d, 12.2 Hz, 1H), 3.10 (d, 12.2
Hz, 1H), 3.32 (dd, 2.8 and 7.8 Hz, 1H), 5.23 (d, 7.1 Hz,
1H), 6.84–6.85 (m, 1H), 7.17–7.19 (m, 1H), 7.26–7.38 (m,
11H), 7.73–7.76 (m, 1H); 13C NMR (75 MHz, CDCl3) l
11.52, 20.05, 20.54, 22.69, 26.96, 31.16, 37.39, 45.59,
46.08, 46.20, 52.27, 53.84, 83.13, 92.00 (d, 26.9 Hz),
128.21–128.54 (Ar, m), 128.83, 129.41, 132.83, 133.77 (d,
19.7 Hz), 134.70 (d, 20.7 Hz), 135.86 (d, 14.5 Hz), 136.45
(d, 10.5 Hz), 136.90 (d, 10.3 Hz), 144.98 (d, 20.7 Hz); 31P
NMR (122 MHz, CDCl3) l −16.0; FAB-MS (m/z) 482
(M+−H, 27); HRMS (FAB) calcd for C32H38NOP+H
484.2768, found 484.2735.
phine–oxazinane such as 5b and demonstrated the pal-
ladium-catalyzed
asymmetric
allylic
alkylation
proceeded using these ligands with a good enantiomeric
excess of up to 95% ee. Further application and modifi-
cation of the ligand 5 are in progress.
References
1. (a) Pfaltz, A.; Lautens, M. In Comprehensive Asymmetric
Catalysis; Jacobsen, E. N.; Pfaltz, A.; Yamamoto, H.,
Eds.; Springer: Berlin, 1999; Chapter 24; (b) Trost, B. M.;
Van Vranken, D. L. Chem. Rev. 1996, 96, 395–422; (c)
Williams, J. M. J. Synlett 1996, 705; (d) Pfaltz, A. Acc.
Chem. Res. 1993, 26, 339–345; (e) Hayashi, T. In Cataly-
tic Asymmetric Synthesis; Ojima, I., Ed.; VCH: New
York, 1993; p. 325; (f) Consiglio, G.; Waymouth, R. M.
Chem. Rev. 1989, 89, 257–276 and references cited
therein.
2. (a) Steinhagen, H.; Reggelin, M.; Helmchem, G. Angew.
Chem.. Int. Ed. Engl. 1997, 36, 2108–2110; (b) Imai, Y.;
Zhang, W.; Kida, T.; Nakatsuji, Y.; Ikeda, I. Tetrahedron
Lett. 1998, 39, 4343–4346; (c) Pretot, R.; Pfaltz, A.
Angew. Chem.. Int. Ed. Engl. 1998, 37, 323–325 and
references cited therein.
Selected data for 5c: [h]2D0=−41.5° (c 0.11, CHCl3); 1H
NMR (300 MHz, CDCl3) l 0.72 (t, 7.3 Hz, 3H), 0.90 (s,
3H), 0.94–1.68 (m, 8H), 1.41 (s, 3H), 1.78–1.84 (m, 1H),
2.01–2.09 (m, 1H), 2.04 (d, 12.1 Hz, 1H), 2.17 (br, 3H),
3.10 (d, 12.2 Hz, 1H), 3.32 (dd, 2.8 and 7.8 Hz, 1H), 5.23
(d, 7.1 Hz, 1H), 6.84–6.87 (m, 1H), 7.17–7.19 (m, 1H),
7.26–7.36 (m, 11H), 7.72–7.74 (m, 1H); 31P NMR (122
MHz, CDCl3) l −16.1; FAB-MS (m/z) 496 (M+−H, 97);
HRMS (FAB) calcd for C33H40NOP+H 498.2926, found
498.2878.
3. Evans, P. A.; Brandt, T. A. Tetrahedron Lett. 1996, 37,
9143–9146.
1
Selected data for 5d: [h]2D0=−156.0° (c 0.03, CHCl3); H
NMR (300 MHz, CDCl3) l 0.85 (s, 3H), 0.86–0.92 (m,
2H), 1.23–1.28 (m, 4H), 1.52 (s, 3H), 1.57–1.59 (m, 1H),
2.52–2.57 (m, 1H), 3.02 (d, 14.3 Hz, 1H), 3.10 (d, 12.3
Hz, 1H), 3.68 (d, 14.3 Hz, 1H), 3.79 (d, 12.3 Hz, 1H),
5.19 (d, 6.9 Hz, 1H), 6.74–6.75 (m, 1H), 7.07–7.10 (m,
6H), 7.23–7.36 (m, 11H), 7.75–7.82 (m, 1H); 31P NMR
(122 MHz, CDCl3) l −14.4; FAB-MS (m/z) 530 (M+−H,
18); HRMS (FAB) calcd for C36H38NOP+H 532.2769,
found 532.2747.
4. Jin, M.-J.; Jung, J.-A.; Kim, S.-H. Tetrahedron Lett.
1999, 40, 5197–5198.
5. Okuyama, Y.; Nakano, H.; Hongo, H. Tetrahedron:
Asymmetry 2000, 11, 1193–1198.
6. (a) Nakano, H.; Okuyama, O.; Hongo, H. Tetrahedron
Lett. 2000, 41, 4615–4618; (b) Nakano, H.; Okuyama, O.;
Yanagida, M.; Hongo, H. J. Org. Chem. 2001, 66, 620–
625.
7. Bartlett, P. D.; Knox, L. H. Org. Synth. Coll. Vol. 5 1973,
689–691.
9. (a) Pena-Cabrera, E.; Norrby, P.-O.; Sjoegren, M.;
Vitagliano, A.; De Felice, V.; Oslob, J.; Ishii, S.; O’Neill,
D.; Kermark, B.; Helquist, P. J. Am. Chem. Soc. 1996,
118, 4299–4313; (b) Mino, T.; Imiya, W.; Yamashita, M.
Synlett 1997, 583–584; (c) Mino, T.; Shiotsuki, M.;
Yamamoto, N.; Suenaga, T.; Sakamoto, M.; Fujita, T.;
Yamashita, M. J. Org. Chem. 2001, 66, 1795–1797.
10. (a) Nomura, N.; Mermet-Bouvier, Y. C.; RajanBabu, T.
V. Synlett 1996, 745–746; (b) Clyne, D.; Mermet-Bouvier,
Y.; Nomura, N.; RajanBabu, T. V. J. Org. Chem. 1999,
64, 7601–7611; (c) Yan, Y.-Y.; RajanBabu, T. V. Org.
Lett. 2000, 2, 199–202.
8. Selected data for 5a: [h]2D0=−39.0° (c 0.10, CHCl3); 1H
NMR (300 MHz, CDCl3) l 0.83 (t, 7.1 Hz, 3H), 0.83–
1.02 (m, 2H), 0.90 (s, 3H), 1.34–1.69 (m, 5H), 1.39 (s,
3H), 1.76–1.84 (m, 1H), 2.09 (d, 12.2 Hz, 1H), 2.13–2.22
(m, 1H), 3.12 (d, 12.2 Hz, 1H), 3.28 (dd, 2.9 and 7.8 Hz,
1H), 5.22 (d, 7.1 Hz, 1H), 6.83–6.85 (m, 1H), 7.17–7.18
(m, 1H), 7.25–7.36 (m, 11H), 7.73–7.77 (m, 1H); 31P
NMR (122 MHz, CDCl3) l −15.9; FAB-MS (m/z) 468
(M+−H, 70); HRMS (FAB) calcd for C31H36NOP+H
470.2613, found 470.2595
Selected data for 5b: [h]2D0=−50.3° (c 0.10, CHCl3); 1H
.